Pembrolizumab is an anti-cancer monoclonal antibody used to treat various cancers, including melanoma and lung cancer. It works by inhibiting the PD-1 pathway, enhancing the immune response against tumors. This medication is essential for managing cancer. In summary, Pembrolizumab is effective in treating advanced cancers.
Pembrolizumab blocks the PD-1 receptor on T-cells, preventing its interaction with PD-L1 and PD-L2, thereby enhancing anti-tumor immunity.